ArticleCancers2021

Differential but Concerted Expression of HSD17B2, HSD17B3, SHBG and SRD5A1 Testosterone Tetrad Modulate Therapy Response and Susceptibility to Disease Relapse in Patients with Prostate Cancer.

Oluwaseun Adebayo Bamodu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.